Can you provide the last earnings date for EVOKE PHARMA INC?
EVOKE PHARMA INC (EVOK) last reported earnings on 11/13/2025.
EVOKE PHARMA INC (EVOK) Earnings History & Surprises
NASDAQ:EVOK • US30049G3020
Current stock price
11 USD
+0.04 (+0.36%)
Last:
EVOK Earnings overview
Past quarterly earnings results for EVOKE PHARMA INC (EVOK), including EPS and revenue actuals, analyst estimates, and surprise percentages. This page focuses on historical performance (not forecasts).
Earnings Snapshot
Next Earnings Date
Upcoming- Release Date
- Mar 11, 2026
- Period
- Q4 / 2025
- EPS Estimate
- -$0.31
- Revenue Estimate
- 4.954M
Last Reported
Most Recent- Release Date
- Nov 13, 2025
- Period
- Q3 / 2025
- EPS Reported
- -$0.45
- EPS Surprise
- 1.96%
- Revenue Surprise
- -2.92%
Beat Rate
Last 8 Quarters 31%
EPS and Revenue beats vs estimates
Quarterly Earnings Historical Results
EPS & Revenue History (in USD): Actual vs estimated values, surprises, q2q growth and acceleration numbers quarterly history.
| Quarter | EPS | EPS Est | EPS Surprise | EPS Q2Q | Revenue | Revenue Est | Revenue Surprise | Revenue Q2Q |
|---|---|---|---|---|---|---|---|---|
| Q3 2025 | -0.45 | -0.46 | 1.96% | 52.13% | 4.284M | 4.413M | -2.92% | 61.42% |
| Q2 2025 | -0.62 | -0.31 | -102.61% | 33.33% | 3.752M | 3.872M | -3.10% | 47.08% |
| Q1 2025 | -0.51 | -0.34 | -51.52% | 75.00% | 3.08M | 3.382M | -8.93% | 77.47% |
| Q4 2024 | -0.63 | -0.64 | 1.96% | 91.10% | 3.309M | 3.146M | 5.18% | 97.44% |
| Q3 2024 | -0.94 | -0.39 | -142.52% | 84.64% | 2.654M | 3.425M | -22.51% | 69.82% |
| Q2 2024 | -0.93 | -0.73 | -26.63% | 86.16% | 2.551M | 3.04M | -16.09% | 125.55% |
| Q1 2024 | -2.04 | -2.57 | 20.63% | 74.63% | 1.735M | 2.181M | -20.43% | 114.26% |
| Q4 2023 | -7.08 | -6.12 | -15.69% | -11.32% | 1.676M | 1.665M | 0.66% | 109.50% |
| Q3 2023 | -6.12 | -7.59 | 19.35% | 15.00% | 1.563M | 1.288M | 21.34% | 88.30% |
| Q2 2023 | -6.72 | -8.94 | 24.79% | 21.13% | 1.131M | 1.118M | 1.16% | 145.87% |
| Q1 2023 | -8.04 | -7.10 | -13.25% | 20.24% | 810K | 1.023M | -20.82% | 92.86% |
| Q4 2022 | -6.36 | -6.49 | 1.96% | 26.39% | 800K | 906.78K | -11.78% | 122.22% |
| Q3 2022 | -7.20 | -8.08 | 10.87% | 16.67% | 830K | 583.44K | 42.26% | -10.75% |
| Q2 2022 | -8.52 | -7.34 | -16.01% | 15.48% | 460K | 591.6K | -22.24% | 91.67% |
| Q1 2022 | -10.08 | -5.88 | -71.57% | 12.50% | 420K | 545.7K | -23.03% | 366.67% |
| Q4 2021 | -8.64 | -11.75 | 26.47% | 33.33% | 360K | 517.14K | -30.39% | 1,700.00% |
| Q3 2021 | -8.64 | -10.28 | 15.97% | 25.00% | 930K | 389.64K | 138.68% | - |
| Q2 2021 | -10.08 | -11.75 | 14.22% | 75.00% | 240K | 154.02K | 55.82% | - |
| Q1 2021 | -11.52 | -9.55 | -20.66% | -14.29% | 90K | 849.66K | -89.41% | - |
| Q4 2020 | -12.96 | -19.83 | 34.64% | - | 20K | 861.9K | -97.68% | - |
| Q3 2020 | -11.52 | -12.48 | 7.73% | - | - | - | ||
| Q2 2020 | -40.32 | -11.75 | -243.14% | - | - | - | ||
| Q1 2020 | -10.08 | -7.34 | -37.25% | - | - | - |
Notes
- EPS and Revenue values are non-GAAP when available, otherwise GAAP.
- Surprise % is (Actual - Estimate) / |Estimate|. Green indicates positive surprise, red negative.
- Q2Q % is quarter-over-quarter growth. Green indicates growth, red indicates decline.
- Green right border indicates acceleration for sales or earnings growth. Acceleration is the case when the current Q2Q is above the previous Q2Q.
Earnings Q2Q Performance Trends
EPS Historical Q2Q growth and Acceleration
Revenue Historical Q2Q growth and Acceleration
Surprise distribution (Last 4 Quarters)
EPS beat statistics
EPS beat (4)
2
Average EPS beat (4)
-37.55%
Max EPS beat (4)
1.96%
Min EPS beat (4)
-102.61%
Revenue beat statistics
Revenue beat (4)
1
Average Revenue beat (4)
-2.44%
Max Revenue beat (4)
5.18%
Min Revenue beat (4)
-8.93%
Analysis
In the last 4 quarters, EVOK has beaten EPS estimates in 2 out of 4 releases
EVOK has beaten revenue estimates in 1 out of the last 4 releases
In the last 4 quarters, EVOK reported -37.6% below the EPS estimates on average.
In the last 4 quarters, EVOK reported -2.4% below the revenue estimates on average.
Related analysis
EVOKE PHARMA INC / EVOK Earnings FAQ
Can you provide information on whether EVOKE PHARMA INC beat earnings estimates in the last quarter?
EVOKE PHARMA INC (EVOK) beat EPS estimates and missed revenue estimates in the most recent quarter.
Can you provide information on how often EVOKE PHARMA INC beats earnings estimates?
In the last 4 quarters, EVOKE PHARMA INC (EVOK) has beaten EPS estimates in 2 out of 4 releases.